Assembly Biosciences ASMB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.1M+121% | $72.3M+154% | $37.19M+31.3% | $33.25M+54.8% | $32.15M+148% | ||
| $64.86M+10.1% | $64.81M+15.9% | $61.84M+17.4% | $58.77M+17.6% | $58.91M+27.4% | ||
| $19.78M+10.6% | $19.61M+8.9% | $18.8M-15.0% | $18M-18.4% | $17.88M-20.6% | ||
| $84.64M+10.2% | $84.42M+14.2% | $80.64M+7.9% | $76.77M+6.6% | $76.79M+11.7% | ||
| —— | —— | -$43.45M+6.4% | -$43.52M+13.9% | -$44.63M+20.0% | ||
| $7.16M+42.0% | $6M+7.6% | $4.83M-20.5% | $4.48M-16.4% | $5.04M+12.2% | ||
| —— | —— | -$38.55M+5.5% | -$38.96M+14.6% | -$39.92M+22.3% | ||
| —— | —— | -$4.79+30.8% | -$5.58+35.9% | -$6.23+41.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
